Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Preprint in bioRxiv (August 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Preprint in bioRxiv (August 2024)
Article in ACS Infectious Diseases (July 2024)
Article in PLOS Pathogens (July 2024)